Sabrina Ayelen Gatti

Institutions of which they are part

Predoctoral researcher
Neurodegenerative Diseases

Vall Hebron Institut de Recerca

Sabrina Ayelen Gatti

Institutions of which they are part

Predoctoral researcher
Neurodegenerative Diseases

Vall Hebron Institut de Recerca

Related news

Pacient d'un assaig clínic a la consulta

VHIR exceeds 700 active clinical trials to achieve new therapies for patients

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Infermera i pacient de Parkinson amb teràpia subcutània

A new therapeutic strategy improves the control of motor symptoms in Parkinson's disease

Vall d'Hebron has participated in a phase III clinical trial which confirmed the efficacy and safety of subcutaneous infusion of levodopa therapy.

Pacient amb Parkinson i alumnes de 4t d'ESO jugant a escacs

Vall d'Hebron begins a citizen science project with adolescents and Parkinson's patients

This initiative is part of a pioneering study that seeks to assess how the relationship between different age groups can influence the quality of life and mental health of patients.